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A59-year-old woman with known enteropathy-associated T-cell lymphoma (EATL) pre-sented with weakness and malaise. An electrocardiogram demonstrated sinus tachycardia,right bundle branch block, and anterior ST-segment elevations (A). Cardiac catheteriza-
tion showed patent coronary arteries (B, Online Videos 1 and 2). Echocardiography and cine cardiac
magnetic resonance imaging (MRI) demonstrated asymmetric septal hypertrophy (Online Videos 3 and
4), whereas delayed-enhancement cardiac MRI tissue characterization showed patchy epicardial and
mid-myocardial hyperenhancement, suggestive of hypertrophic cardiomyopathy (C).
Positron emission tomography (PET) revealed marked hypermetabolic activity in the interventricular
septum, corresponding to regional hyperenhancement on MRI (D). Subsequent cardiac septal biopsy (E)
demonstrated infiltration by atypical lymphocytes with irregular nuclear contour and prominent nucleoli;
T-cell morphology was identical to that found in patient’s prior bone marrow biopsy.
EATL, an intestinal tumor of intraepithelial T lymphocytes, is a rare, aggressive disease. Whereas
PET is used to stage EATL, no prior reports have documented cardiac involvement on PET or MRI.
This case demonstrates the importance of integrated metabolic and tissue characterization imaging for
cardiomyopathy assessment.
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